Trulieve Cannabis up 2.48%, trading around $6.2

After closing the previous trading day at $6.05, Trulieve Cannabis is up to $6.2, which makes for a move of 2.48%/15 cents today.

At the same time, United States Participation Rate (Feb) released yesterday at 13:30 UTC with a figure of 118.3, while the previous figure was 62.4.

Trulieve Cannabis Corp.'s lower Bollinger Band® is at $5.85, indicating that the market is oversold and fertile for new buyers.

Following today's unexpected gains, extensive multifactorial technical analysis forecasts Trulieve Cannabis to buck against its prevailing downtrend and begin to turn higher in the short term. With all probabilities considered, the the medical and recreational cannabis provider is expected to pick up significant bullish sentiment in the coming days.

This rally in Trulieve Cannabis's share price coincides with other health care stocks as Stryker is trading at $271.8 after ending yesterday's session at $266.71 (up 1.91%). Thermo Fisher Scientific is trading at $551.92 after ending yesterday's session at $541.21 (up 1.98%). Sanofi added 1.53% to its value, now trading at $47.75.

Also worthy of note, projections for United States Retail Sales are set for a continuation of decline with -0.3% while previous data was 3%; data will be released tomorrow at 12:30 UTC. United States Core Retail Sales projected to decline to -0.1% while previous data was 2.3%; data will be released tomorrow at 12:30 UTC. Tomorrow at 12:30 UTC data for United States Producer Price Index will be released, with an expected decline to 0.3% from the preceding figure of 0.7%.

Having soared to a high of $21.2 approximately 11 months ago, the medical and recreational cannabis provider is now trading 71.46% lower.